Yahoo Web Search

Search results

    • Analyst Report: argenx SE

      Morningstar Research via Yahoo Finance· 2 days ago

      Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December ...

    • Q1 2024 Fulgent Genetics Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 16 hours ago

      Building up our nine article technology, we are also developing next-generation antibody drug conjugate ADC technology platform that could potentially provide even broader ...

    • Q1 2024 Vir Biotechnology Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 1 day ago

      ...by the National Institute of Allergy and Infectious Diseases, part of the NIH and the Bill & Melinda Gates Foundation in research, we continue to advance multiple investigational antibody therapeutics optimized for increased likelihood of development success, thanks to our proprietary platform...